January 2026: Nutromics Lab-on-a-Patch

Skin-worn patch enabling continuous, real-time biomarker monitoring for personalized healthcare.

Image credits: Nutromics

We are excited to introduce Nutromics’ Lab-on-a-Patch®, a next-generation wearable designed to revolutionize medical diagnostics with real-time, continuous biomarker monitoring. This ultra-thin skin patch combines cutting-edge DNA-based biosensors and microneedle technology to deliver hospital-grade health insights without repeated blood draws. Unlike traditional diagnostics that provide only isolated data points, the Lab-on-a-Patch offers continuous, multiplexed monitoring of multiple biomarkers, bringing actionable health intelligence directly into everyday life.

Seamlessly integrated with wireless connectivity and cloud-ready data streams, the patch enables clinicians and health systems to receive real-time updates and personalize care. Whether in intensive care, emergency settings, or at home, it provides comfort, precision, and uninterrupted monitoring without compromise.

About Nutromics Lab-on-a-Patch

Created to transform healthcare wearables, the Lab-on-a-Patch redefines diagnostics by continuously tracking molecular targets - from drug levels to critical health indicators. By integrating advanced biosensing into a simple wearable patch, Nutromics is shaping a future where diagnostics are proactive, personalized, and seamlessly woven into daily health management.

Sam Draper
January 1, 2026

January

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

March 2023: Implandata Ophthalmic Products GmbH

Leading the digital transformation of glaucoma care!

New Brain Implant Decodes A Person's 'Inner Monologue'

Stanford scientists create brain-computer interface to record and decode inner monologue.

Oscar Closes $140M New Funding Round, Led By Tiger Global Management

Oscar Health, a New York City-based health insurance technology company, has raised $140 million...

Biofourmis Raises $100 Million In Series C Funding To Accelerate Global Expansion

Biofourmis, which combines AI-based data analytics and biosensors to monitor the progress of med...
Discover more